"Quick Analysis" above starts the Research Desk from this K-line and runs one quick pass: three analyst lenses (macro, fundamentals, technicals) plus a trade plan and risk statistics, usually in about 30 s and up to 5 minutes when upstream is slow. For the five-team deep research and the institutional report, switch the mode to Deep inside the Research Desk.
1-YEAR PRICE
One-Year Trajectory
RISK-OFF251 BARS · -25.5% YOY
2025-10-29$51.37 → $38.29 (-25.5%)2026-10-28
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Smart Money
Loading § Smart Money
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE. Sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). Server-rendered values are cached for up to 60 minutes via ISR; the quote refreshes in your browser.
⚠ DCF unavailable: the interest classification in operating cash flow is unverified, so operating cash flow cannot be reconciled to FCFF. Financial evidence and eligible comparables remain available. · Peers swapped to "GLP-1 + obesity platform" cohort: Ozempic/Wegovy market-share leader. Same secular driver as LLY.
FINANCIALS
Multi-Year Financials (SEC XBRL)
CALMYOY REV +6.4% · 4 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$309.06B
$102.43B
$119.10B
$58.96B
$542.90B
2024-12
$290.40B
$100.99B
$120.97B
$73.80B
$465.63B
2023-12
$232.26B
$83.68B
$108.91B
$83.10B
$314.49B
2022-12
$176.95B
$55.52B
$78.89B
$66.74B
$241.26B
SMART MONEY
NVO — Who Is Buying
—NO TRACKED HOLDERS THIS QUARTER · 0 MEMBERS
No smart-money filings for NVO right now: none of the filers we track disclosed a position this quarter, and no member of Congress disclosed a trade.
Congressional disclosures
No member of Congress has filed a disclosed trade in this stock. The STOCK Act covers US-listed securities only, and filings arrive 30-45 days after the trade.
Last updated 2026-10-29 · Sources: SEC EDGAR 13F and US Congress STOCK Act disclosures Not investment advice. 13Fs are quarterly and land up to 45 days after the quarter ends; Congressional disclosures are also up to 45 days late and report a value RANGE, never an exact amount.